Bausch Health (BHC) | Stock Overview & Key Data

Bausch Health Companies Inc. | Healthcare

$4.45

-1.11%

| Bausch Health Stock Comparison:

Bausch Health vs Zoetis Bausch Health vs Haleon Plc - ADR Bausch Health vs Kiniksa Bausch Health vs Supernus Bausch Health vs BGM Bausch Health vs S&P 500 | Market

Bausch Health Performance Comparison

Loading chart data...

Bausch Health

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $4.41 High: $4.48

on May 23, 2025

52 Week Range

Low: $3.96 High: $9.85

on July 24, 2024

on November 4, 2024

All-Time High: $263.81 on August 3, 2015

Key Statistics

Market Cap i $1.7B

EPS i -0.12

P/E Ratio (TTM) i -34.62

Forward P/E i 1.02

P/B Ratio i -6.80

PEG Ratio i 1.02

Div. Yield i 28.44%

ROE i 14.29%

Beta i 0.343

Debt to Equity i -89.63

Financial Highlights

Profitability

Gross Margin i 68.97%

Operating Margin i 11.91%

Profit Margin i -0.41%

Returns and Earnings

Return on Assets (TTM) i 4.31%

Return on Equity (TTM) i 14.29%

EBITDA i $3.1B

Net Income (TTM) i $-40.0M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i N/A

Dividend Information

Expected Yearly Dividend i $4.00

Estimated Dividend Yield i 88.89%

5 Year Average Dividend Yield i 6.52%

Last 12-Month Dividend Yield i 28.44%

Last 12-Month Dividend i $1.28

% of Earnings Paid as Dividends i 0.00%

Dividend Date i N/A

Ex-Dividend Date i November 10, 2010

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Bausch Health BHC	1.66B Small-cap	-4.71%	-13.93%	-37.94%	-44.03%	-43.95%	-30.03%	-54.91%	-75.92%
Zoetis ZTS	71.48B Large-cap	-0.28%	7.73%	-1.65%	-9.03%	-0.02%	-4.42%	-5.54%	16.62%
Haleon Plc - ADR HLN	49.99B Large-cap	3.15%	8.90%	9.75%	16.28%	18.01%	32.94%	50.34%	50.34%
Kiniksa KNSA	1.90B Small-cap	2.44%	28.78%	36.98%	23.35%	34.85%	41.21%	233.33%	28.89%
Supernus SUPN	1.81B Small-cap	-3.98%	4.09%	-1.77%	-11.08%	-11.89%	16.54%	12.89%	32.92%
BGM BGM	2.27B Mid-cap	16.91%	34.99%	46.89%	108.24%	63.98%	234.10%	65.71%	-66.86%

Ownership & Short Interest

Insider Ownership i 10.83%

Institutional Ownership i 67.35%

Shares Short i 10M

Short Ratio i 3.30

Short % of Shares Outstanding i 2.88%

Average 10-Day Volume i 1M

Average 90-Day Volume i 2M

Bausch Health Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Bausch Health would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is BHC's 52-week high and low?

In the last 52 weeks, Bausch Health reached a high of $9.85 (on November 4, 2024) and a low of $3.96 (on July 24, 2024).

What is the market cap and P/E ratio for BHC?

Curious about Bausch Health's size and valuation? Its market capitalization stands at 1.66B. When it comes to valuation, the P/E ratio (trailing twelve months) is -34.62, and the forward P/E (looking ahead) is 1.02.

Does BHC pay dividends? If so, what's the yield?

Yes, Bausch Health is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 28.44%, and the company is expected to pay out $4.00 per share over the coming year.

Who are Bausch Health's main competitors or similar companies to consider before investing?

When looking at Bausch Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Zoetis ZTS	71.48B	Healthcare	Drug Manufacturers - Specialty & Generic	-4.42%	-5.54%
Haleon Plc - ADR HLN	49.99B	Healthcare	Drug Manufacturers - Specialty & Generic	32.94%	50.34%
Kiniksa KNSA	1.90B	Healthcare	Drug Manufacturers - Specialty & Generic	41.21%	233.33%
Supernus SUPN	1.81B	Healthcare	Drug Manufacturers - Specialty & Generic	16.54%	12.89%
BGM BGM	2.27B	Healthcare	Drug Manufacturers - Specialty & Generic	234.10%	65.71%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Bausch Health Companies Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Bausch Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 14.29%, the Debt to Equity ratio from the most recent quarter is -89.63, and its Gross Profit Margin stands at 68.97%.

What is the recent revenue and earnings growth for BHC?

Looking at Bausch Health's growth, its revenue over the trailing twelve months (TTM) was $10B. Compared to the same quarter last year (YoY), quarterly revenue grew by 4.90%, and quarterly earnings saw a YoY growth of N/A.

How much of BHC stock is held by insiders and institutions?

Wondering who owns Bausch Health stock? Company insiders (like executives and directors) hold about 10.83% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 67.35%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.